Onward Medical NV (XBRU:ONWD) Cash-to-Debt : 1.76 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Onward Medical NV's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.76.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Onward Medical NV could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Onward Medical NV's Cash-to-Debt or its related term are showing as below:

XBRU:ONWD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15 Med: 0.68 Max: 6.55
Current: 1.76

During the past 7 years, Onward Medical NV's highest Cash to Debt Ratio was 6.55. The lowest was 0.15. And the median was 0.68.

XBRU:ONWD's Cash-to-Debt is ranked worse than
69.22% of 1527 companies
in the Biotechnology industry
Industry Median: 6.24 vs XBRU:ONWD: 1.76

Onward Medical NV Cash-to-Debt Historical Data

The historical data trend for Onward Medical NV's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Onward Medical NV Cash-to-Debt Chart

Onward Medical NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.45

0.15

6.55

4.30

1.76

Onward Medical NV Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial					6.55	5.50	4.30	2.76	1.76

Competitive Comparison of Onward Medical NV's Cash-to-Debt

For the Biotechnology subindustry, Onward Medical NV's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Cash-to-Debt falls into.

Onward Medical NV Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Onward Medical NV's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	29.768	/	(0.568	+	16.306)
	=	1.76

Onward Medical NV's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	29.768	/	(0.568	+	16.306)
	=	1.76

Onward Medical NV (XBRU:ONWD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Onward Medical NV Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Onward Medical NV (XBRU:ONWD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

ONWRF:USA 63E:Germany

Address

High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE

Website

https://www.onwd.com

Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines